Privia Health Group’s (PRVA) Buy Rating Reiterated at Needham & Company LLC

Privia Health Group (NASDAQ:PRVA)‘s stock had its “buy” rating reaffirmed by equities research analysts at Needham & Company LLC in a research report issued on Friday,Benzinga reports. They currently have a $30.00 target price on the stock. Needham & Company LLC’s target price would suggest a potential upside of 28.81% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. JMP Securities set a $29.00 target price on shares of Privia Health Group in a research note on Friday, February 28th. Canaccord Genuity Group lifted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 28th. Stephens restated an “overweight” rating and set a $26.00 target price on shares of Privia Health Group in a research report on Thursday, January 2nd. Macquarie initiated coverage on Privia Health Group in a research note on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Finally, Piper Sandler raised their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, February 28th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Privia Health Group currently has an average rating of “Buy” and an average price target of $26.67.

Privia Health Group Price Performance

Privia Health Group stock opened at $23.29 on Friday. The firm has a market cap of $2.81 billion, a P/E ratio of 232.92, a P/E/G ratio of 3.47 and a beta of 0.85. The stock’s 50 day moving average is $23.59 and its 200 day moving average is $21.00. Privia Health Group has a one year low of $15.92 and a one year high of $26.04.

Institutional Investors Weigh In On Privia Health Group

Institutional investors have recently bought and sold shares of the stock. First Horizon Advisors Inc. grew its position in Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares in the last quarter. Financial Management Professionals Inc. purchased a new stake in shares of Privia Health Group during the fourth quarter valued at approximately $51,000. Quarry LP lifted its holdings in Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after acquiring an additional 2,533 shares during the period. Finally, KBC Group NV boosted its position in Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.